"First-Generation American Challenges Booker's Senate Seat," coverage by NewsMax, October 17, 2019, featuring Adjunct Professor Rikin Mehta.
B.S., Rutgers; Pharm.D., University of Arkansas; J.D., Rutgers; LL.M., Georgetown
Rikin Mehta is the Head of Regulatory Affairs for Aquestive Therapeutics where he leads regulatory law and affairs for all medical product and drug development efforts. Prior to Aquestive, Dr. Mehta served as Head of US Regulatory Policy for Pfizer Consumer Healthcare. Prior to his private sector engagements, Dr. Mehta served in a political appointment as the Senior Deputy Director for the Health Regulation and Licensing Administration for the DC Department of Health. Dr. Mehta also worked at the U.S. Food and Drug Administration (FDA) where he served as the Deputy Director for the Division of Medical Policy Programs at the Center for Drug Evaluation and Research (CDER), Office of Medical Policy. As the Deputy, Dr. Mehta created and led an Initiative exploring regulatory methods to alleviate the under-treatment of common conditions or diseases through the use of innovative technologies or other conditions of safe use to expand access to medications along with ensuring industry compliance for the drug approval process. Prior to his law career, Dr. Mehta worked as a drug store pharmacist as well as an emergency room/critical care pharmacist at a university hospital. Rik received his B.S. in pharmacy from Rutgers University and Pharm.D. from the University of Arkansas for Medical Sciences. He later received a J.D. from Rutgers University School of Law and a Master of Laws in Global Health Law and International Institutions through a joint program with Georgetown University Law Center and the Graduate Institute for International and Development Studies in Geneva, Switzerland. Dr. Mehta is originally from Houston, Texas.